×
About 2,615 results

ALLMedicine™ Japanese Encephalitis Center

Research & Reviews  925 results

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against...
https://doi.org/10.1080/21645515.2022.2079323
Human Vaccines & Immunotherapeutics; Shoushtari M, Roohvand F et. al.

Jun 18th, 2022 - Flaviviruses are arthropod-borne viruses (arboviruses) that have been recently considered among the significant public health problems in defined geographical regions. In this line, there have been vaccines approved for some flaviviruses including...

Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Pr...
https://doi.org/10.1016/S2214-109X(22)00174-7
The Lancet. Global Health; Pommier JD, Gorman C et. al.

Jun 18th, 2022 - Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing...

Infectious causes of acute encephalitis syndrome hospitalizations in Central India, 201...
https://doi.org/10.1016/j.jcv.2022.105194
Journal of Clinical Virology : the Official Publication O... Tandale BV, Tomar SJ et. al.

Jun 11th, 2022 - We enhanced surveillance of hospitalizations of all ages for acute encephalitis syndrome (AES) along with infectious aetiologies, including the Japanese encephalitis virus (JEV). From October 2018 to September 2020, we screened neurological patien...

Lipases secreted by a gut bacterium inhibit arbovirus transmission in mosquitoes.
https://doi.org/10.1371/journal.ppat.1010552
PLoS Pathogens; Yu X, Tong L et. al.

Jun 10th, 2022 - Arboviruses are etiological agents of various severe human diseases that place a tremendous burden on global public health and the economy; compounding this issue is the fact that effective prophylactics and therapeutics are lacking for most arbov...

see more →

Guidelines  2 results

Use of Japanese encephalitis vaccine in children: recommendations of the advisory commi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585349
MMWR. Morbidity and Mortality Weekly Report;

Nov 15th, 2013 - On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to includ...

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunizati...
https://www.ncbi.nlm.nih.gov/pubmed/20224546
MMWR. Recommendations and Reports : Morbidity and Mortali... Fischer M, Lindsey N et. al.

Mar 13th, 2010 - This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  67 results

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV
https://clinicaltrials.gov/ct2/show/NCT01190228

Mar 28th, 2022 - Study participants who are previously immunized with JE-CV vaccine will receive a booster dose of the JE-CV vaccine and will be followed up for 5 years for immunogenicity. The control (JE-CV naïve) participants will receive either one dose of JE-C...

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects
https://clinicaltrials.gov/ct2/show/NCT02492165

Mar 28th, 2022 - Study participants will be enrolled by age group and will each receive one injection of IMOJEV® on Day 0 given as primary vaccination. They will be assessed for immunogenicity and safety, post-vaccination.

Purified Inactivated Japanese Encephalitis Vaccine
https://clinicaltrials.gov/ct2/show/NCT04223037

Mar 9th, 2022 - The clinical study used randomized, blind method, commercialize inactivated Japanese encephalitis vaccine as control. In Infants at 6-23 months of age were injected with experimental vaccine with 0,7 days and 0,28 days vaccination schedule to eval...

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
https://clinicaltrials.gov/ct2/show/NCT01041573

Jul 27th, 2021 - Open-label, randomized, active controlled Phase 3 study in children aged ≥ 2 months to < 18 years. Subjects aged ≥ 2 months to < 12 months were randomized in a 2:1 ratio to receive IC51 (0.25 ml dose) or Prevnar® as a safety comparator. Children a...

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province
https://clinicaltrials.gov/ct2/show/NCT04817917

Apr 1st, 2021 - Based on the retrospective registry in Zhejiang Provincial Immunization Information System, healthy children aged 6 years from 5 cohorts were included according to their previous immunization schedules on JE: 3 doses of JEV-I (Group 1), JEV-L+ JEV...

see more →

News  51 results

What’s Eating You? Culex Mosquitoes and West Nile Virus
https://www.mdedge.com/dermatology/article/239895/infectious-diseases/whats-eating-you-culex-mosquitoes-and-west-nile-virus
Marissa Lobl, BS, Taylor Kay Thieman, BS et. al.

May 11th, 2021 - What is West Nile virus? How is it contracted, and who can become infected? West Nile virus (WNV) is a single-stranded RNA virus of the Flaviviridae family and Flavivirus genus, a lineage that also includes the yellow fever, dengue, Zika, Japanese.

Valneva's COVID-19 Shot Set for Phase Three Trial This Month
https://www.medscape.com/viewarticle/948794

Apr 7th, 2021 - PARIS (Reuters) - Valneva on Tuesday reported positive results for its COVID-19 vaccine in early stage clinical trials and said it planned to launch a Phase Three trial this month. The French drugmaker, whose shot uses the technology behind its li...

What's the Latest on COVID-19 Vaccines and Will You Have a Jab?
https://www.medscape.com/viewarticle/941111

Nov 18th, 2020 - Editor's note, 25 November 2020: The reader poll has now closed. The results are published here Novavax Novavax expects to fully enrol phase 3 clinical trials of its NVX-CoV2373 candidate in the UK by the end of November. Trials in the US and Mexi...

Smallpox Vaccination-Associated Myopericarditis
https://www.mdedge.com/fedprac/article/228071/vaccines/smallpox-vaccination-associated-myopericarditis
Jerry Fan, MD, Hameed Ali, DO

Sep 4th, 2020 - A renewed effort to vaccinate service members fighting the global war on terrorism has brought new diagnostic challenges. Vaccinations not generally given to the public are routinely given to service members when they deploy to various parts of th.

Pregnant Women May Not Have Safety Risks With Common Travel Vaccines
https://www.medscape.com/viewarticle/921760

Nov 26th, 2019 - (Reuters Health) - Many common travel vaccines don't have known safety risks for pregnant women, although a research review also suggests that evidence is limited for some inoculations. Researchers examined data from trials of common travel vaccin...

see more →